QCG
TMCI icon

Quadrant Capital Group’s Treace Medical Concepts TMCI Stock Holding History

Quadrant Capital Group’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-688
Closed -$1.69K – 2806
2025
Q4 		$1.69K Sell
688
-96
-12% -$417 ﹤0.01% 2544
2025
Q3 		$5.26K Buy
+784
New +$5.12K ﹤0.01% 2316
2025
Q2 		– Sell
-784
Closed -$6.58K – 2510
2025
Q1 		$6.58K Hold
784
– – ﹤0.01% 2303
2024
Q4 		$5.83K Buy
784
+765
+4,026% +$5.12K ﹤0.01% 2267
2024
Q3 		$111 Buy
+19
New +$122 ﹤0.01% 2720
2024
Q2 		– Sell
-1,423
Closed -$18.6K – 2768
2024
Q1 		$18.6K Buy
1,423
+25
+2% +$333 ﹤0.01% 1879
2023
Q4 		$17.8K Buy
+1,398
New +$14.1K ﹤0.01% 1868

Other funds holding TMCI

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
GS
Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $74.4B AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quadrant Capital Group's TMCI Position: Q1 2026 in Review

Quadrant Capital Group sold out of Treace Medical Concepts (TMCI) in Q1 2026, closing a stake of 688 shares — an estimated $1.69K sold.

Quadrant Capital Group first reported a position in TMCI in Q4 2023 and held it in 7 quarters. The position peaked at $18.6K in Q1 2024. 118 funds tracked by Wall St. Rank hold TMCI as of Q1 2026.

  • Quadrant Capital Group reported no remaining Treace Medical Concepts position as of Q1 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 688 Treace Medical Concepts shares in Q1 2026, an estimated $1.69K.
  • Quadrant Capital Group first reported a position in Treace Medical Concepts in Q4 2023 and held it in 7 quarters.
  • Quadrant Capital Group's Treace Medical Concepts position peaked at $18.6K in Q1 2024.
  • 118 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q1 2026.

Based on Quadrant Capital Group's 13F filing for Q1 2026, filed 11 May 2026.